Dr. Richy Agajanian, MD
Claim this profileInnovative Clinical Research Institute
Studies Lymphoma
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
20 drugs studied
Area of expertise
1Lymphoma
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Richy Agajanian, MD is currently running
CAB-ROR2-ADC + PD-1 Inhibitor
for Breast Cancer
This trial is testing a new targeted cancer treatment called CAB-ROR2-ADC in patients with advanced solid tumors. The drug seeks out cancer cells with a specific marker and delivers a potent treatment directly to them.
Recruiting1 award Phase 1 & 29 criteria
CAB-AXL-ADC + PD-1 Inhibitor
for Lung Cancer
The objective of this study is to assess safety and efficacy of CAB-AXL-ADC in NSCLC
Recruiting1 award Phase 27 criteria
More about Richy Agajanian, MD
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Richy Agajanian, MD has experience with
- Pirtobrutinib
- Pembrolizumab
- PD-1 Inhibitor
- Vodobatinib (K0706)
- HMPL-523
- Rituximab
Breakdown of trials Richy Agajanian, MD has run
Non-Small Cell Lung Cancer
Leukemia
Lymphoid Leukemia
Chronic B-Cell Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richy Agajanian, MD specialize in?
Richy Agajanian, MD focuses on Lymphoma and Non-Small Cell Lung Cancer. In particular, much of their work with Lymphoma has involved Stage II patients, or patients who are Stage I.
Is Richy Agajanian, MD currently recruiting for clinical trials?
Yes, Richy Agajanian, MD is currently recruiting for 4 clinical trials in Downey California. If you're interested in participating, you should apply.
Are there any treatments that Richy Agajanian, MD has studied deeply?
Yes, Richy Agajanian, MD has studied treatments such as Pirtobrutinib, Pembrolizumab, PD-1 inhibitor.
What is the best way to schedule an appointment with Richy Agajanian, MD?
Apply for one of the trials that Richy Agajanian, MD is conducting.
What is the office address of Richy Agajanian, MD?
The office of Richy Agajanian, MD is located at: Innovative Clinical Research Institute, Downey, California 90241 United States. This is the address for their practice at the Innovative Clinical Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.